Eliglustat - Sanofi
At a glance
- Drug Originator University of Michigan
- Drug Licenced by Sanofi
- Drug Class 2 ring heterocyclic compounds; Amides; Pyrrolidines; Small molecules
- Mechanism of Action Glucosylceramide synthase inhibitors
- USA Patent Applicants GENZYME CORP
- USA Patents 14
- NDAs 1
- International Patents 160
- Patent Applications 79
Table of Contents

Disclaimer